DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.
Primary open angle glaucoma
Patients age 30 or greater with an IOP of 18-26 mmHg
Mild to moderate POAG patients (mild or moderate according to the AAO PPP Guidelines)
DSLT procedure
History of prior glaucoma treatment - this includes past medication use (in either eye), previous lasers or incisional surgery
Angle closure patients
Ocular Hypertension
Baseline VF MD of worse than -12dB
Barnet Dulaney Perkins Eye Centers
Lead sponsor
Alcon, a Novartis Company
Collaborator